Expression of sfa and afa Genes in Uropathogenic Escherichia coli Under Probiotic Effect

Authors

DOI:

https://doi.org/10.54133/ajms.v7i2.1501

Keywords:

afa, Probiotics, sfa, Uropathogenic E. coli, UTIs

Abstract

Background: Urinary tract infections (UTIs) are primarily caused by Escherichia coli. Various genes in UPEC isolates are considered virulence factors that cause illness in humans. Objective: To identify the adhesive genes sfa and afa in UPEC strains isolated from UTI patients that form biofilm and to investigate the impact of probiotics (Lactobacillus acidophilus) on their expression. Methods: Between October and December 2023, 140 samples were obtained from Urinary Tract Infection (UTI) patients and urinary catheter specimens at Al-Yarmouk Hospital and Ghazi Al-Hariri Hospital for Surgical Specialties locations in Baghdad, Iraq. All bacterial isolates were identified using the VITEK-2 system and standard biochemical testing. The isolates were subsequently subjected to PCR to detect adhesive genes sfa and afa using primers that were specifically designed. The MRS broth was centrifuged, and Lactobacillus acidophilus extract was obtained as a result. Then, isolates that contained two genes were subjected to a Lactobacillus acidophilus extract test. Results: The formation of biofilm of UPEC isolates was (33.33%) a strong biofilm-former, (61.90%) a moderate biofilm, and (4.76%) a weak biofilm. The sfa and afa genes were present at a frequency of 80.95% and 14.28%, respectively. At least one adhesive gene was present in most isolates. Conclusions: Most of the isolates showed a decrease in the expression of sfa and afa genes because of the effect of L. acidophilus on gene expression.

Downloads

Download data is not yet available.

References

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432.

Hojati Z, Zamanzad B, Hashemzadeh M, Molaie R, Gholipour A. The FimH gene in uropathogenic Escherichia coli strains isolated from patients with urinary tract infection. Jundishapur J Microbiol. 2015;8(2):e17520. doi: 10.5812%2Fjjm.17520.

Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17(2):227-241. doi: 10.1016/s0891-5520(03)00005-9.

Ejrnæs K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull. 2011;58(4):B4187.

Terlizzi ME, Gribaudo G, Maffei ME. Uropathogenic Escherichia coli (UPEC) infections: Virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566. doi: 10.3389/fmicb.2017.01566.

Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123-140. doi: 10.1038/nrmicro818.

Ott M, Hoschützky H, Jann K, Van Die I, Hacker J. Gene clusters for S fimbrial adhesin (sfa) and F1C fimbriae (foc) of Escherichia coli: comparative aspects of structure and function. J Bacteriol. 1988;170(9):3983-3990. doi: 10.1128%2Fjb.170.9.3983-3990.1988.

Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol. 1992;30(5):1189-1193. doi: 10.1128/jcm.30.5.1189-1193.1992.

Ishitoya S, Yamamoto S, Kanamaru S, Kurazono H, Habuchi T, Ogawa O, et al. Distribution of afaE adhesins in Escherichia coli isolated from Japanese patients with urinary tract infection. J Urol. 2003;169(5):1758-1761. doi: 10.1097/01.ju.0000057968.53213.b1.

Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW, et al. Biofilm formation by uropathogenic Escherichia coli is favored under oxygen conditions that mimic the bladder environment. Int J Mol Sci. 2017;18(10). doi: 10.3390/ijms18102077.

Zuccotti GV, Meneghin F, Raimondi C, Dilillo D, Agostoni C, Riva E, et al. Probiotics in clinical practice: an overview. J Int Med Res. 2008;36 Suppl 1:1a-53a.

Quigley EM. Prebiotics and probiotics in digestive health. Clin Gastroenterol Hepatol. 2019;17(2):333-344. doi: 10.1016/j.cgh.2018.09.028.

Ghane M, Babaeekhou L, Ketabi SS. Antibiofilm activity of Kefir probiotic Lactobacilli against uropathogenic Escherichia coli (UPEC). Avicenna J Med Biotechnol. 2020;12(4):221-229.

Gao H, Li X, Chen X, Hai D, Wei C, Zhang L, et al. The functional roles of Lactobacillus acidophilus in different physiological and pathological processes. J Microbiol Biotechnol. 2022;32(10):1226-12233.

Mital BK, Garg SK. Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus. Crit Rev Microbiol. 1995;21(3):175-214. doi; 10.3109/10408419509113540.

Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol. 2005;16(2):204-211. doi: 10.1016/j.copbio.2005.02.003.

O'Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011(47). doi: 10.3791%2F2437.

Kaur S, Sharma P, Kalia N, Singh J, Kaur S. Anti-biofilm Properties of the fecal probiotic Lactobacilli against Vibrio spp. Front Cell Infect Microbiol. 2018;8:120. doi: 10.3389/fcimb.2018.00120.

Boye A, Siakwa PM, Boampong JN, Koffuor G, Kwabena R, Ephraim D, et al., (Eds.), Asymptomatic urinary tract infections in pregnant women attending antenatal clinic in Cape Coast, Ghana 2012.

Müller D, Greune L, Heusipp G, Karch H, Fruth A, Tschäpe H, et al. Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR. Appl Environ Microbiol. 2007;73(10):3380-3390. doi: 10.1128%2FAEM.02855-06.

Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012;2012:681473. doi: 10.1155%2F2012%2F681473.

Bjarnsholt T, Ciofu O, Molin S, Givskov M, Høiby N. Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov. 2013;12(10):791-808. doi: 10.1038/nrd4000.

Boll EJ, Struve C, Boisen N, Olesen B, Stahlhut SG, Krogfelt KA. Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect Immun. 2013;81(4):1164-1171. doi: 10.1128%2FIAI.01376-12.

Rao KP, Chennappa G, Suraj U, Nagaraja H, Raj AP, Sreenivasa MY. Probiotic potential of lactobacillus strains isolated from sorghum-based traditional fermented food. Probiotics Antimicrob Proteins. 2015;7(2):146-156. doi: 10.1007/s12602-015-9186-6.

Blanco M, Blanco JE, Alonso MP, Mora A, Balsalobre C, Muñoa F, et al. Detection of pap, sfa and afa adhesin-encoding operons in uropathogenic Escherichia coli strains: Relationship with expression of adhesins and production of toxins. Res Microbiol. 1997;148(9):745-755. doi: 10.1016/s0923-2508(97)82450-3.

Santo E, Macedo C, Marin JM. Virulence factors of uropathogenic Escherichia coli from a university hospital in Ribeirão Preto, São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2006;48(4):185-188. doi: 10.1590/s0036-46652006000400002.

Silveira WD, Benetti F, Lancellotti M, Ferreira A, Solferini VN, Brocchi M. Biological and genetic characteristics of uropathogenic Escherichia coli strains. Rev Inst Med Trop Sao Paulo. 2001;43(6):303-310. doi: 10.1590/s0036-46652001000600001.

Downloads

Published

2024-11-08

How to Cite

Khalid, A. N., & Abu-Resha , R. A. (2024). Expression of sfa and afa Genes in Uropathogenic Escherichia coli Under Probiotic Effect. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 7(2), 66–71. https://doi.org/10.54133/ajms.v7i2.1501

Issue

Section

Original article

Similar Articles

You may also start an advanced similarity search for this article.